Published in Arch Neurol on April 01, 1993
Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology (2000) 2.73
Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol (1996) 1.39
Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol (2001) 0.87
The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease. J Neural Transm (Vienna) (2006) 0.84
Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study. Psychopharmacology (Berl) (2005) 0.78
The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial. Alzheimers Res Ther (2017) 0.75
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Pathogenesis of leukoaraiosis: a review. Stroke (1997) 4.95
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology (2000) 4.13
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology (2007) 3.24
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med (1999) 2.82
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Cerebral white matter is highly vulnerable to ischemia. Stroke (1996) 2.62
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA (2001) 2.24
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke (1999) 2.17
A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke (2001) 2.16
The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology (1995) 2.10
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
Ataxic hemiparesis: critical appraisal of a lacunar syndrome. Stroke (1998) 1.98
Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke (1995) 1.91
The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke (1995) 1.87
Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med (1994) 1.85
Cerebrovascular complications of Fabry's disease. Ann Neurol (1996) 1.78
A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. Stroke (1995) 1.75
Low brain magnesium in migraine. Headache (1989) 1.70
Neuropsychiatric applications of DTI - a review. NMR Biomed (2002) 1.66
Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activator. Pharmacotherapy (1999) 1.65
Subacute sclerosing panencephalitis. A multidisciplinary study of eight cases. JAMA (1969) 1.59
Postischemic (1 hour) hypothermia significantly reduces ischemic cell damage in rats subjected to 2 hours of middle cerebral artery occlusion. Stroke (1993) 1.55
Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke (1998) 1.55
Correction of motional artifacts in diffusion-weighted MR images using navigator echoes. Magn Reson Imaging (1994) 1.54
Time course of ADCw changes in ischemic stroke: beyond the human eye! Stroke (1998) 1.54
Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology (1995) 1.52
Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology (1998) 1.51
Neuronal ischemic injury: light microscopy, ultrastructure and biochemistry. Acta Neuropathol (1978) 1.50
Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol (1986) 1.50
Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology (2000) 1.48
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48
Spectrum of patients with EMG features of polyradiculopathy without neuropathy. Muscle Nerve (1990) 1.40
Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol (2007) 1.38
Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke (2001) 1.38
Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology (2001) 1.37
Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Stroke (2000) 1.35
Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke (1996) 1.31
Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol (1999) 1.30
Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats. Stroke (1994) 1.27
Cocaine and stroke. Stroke (1988) 1.27
Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J Neurol Sci (1994) 1.27
Cerebellar infarction. Clinical and anatomic observations in 66 cases. Stroke (1993) 1.26
The neuropathology of stroke. Hum Pathol (1975) 1.25
Cerebellar hemangioblastoma: histogenesis of stroma cells. Cancer (1973) 1.19
Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology (1996) 1.17
Creatine use among young athletes. Pediatrics (2001) 1.17
Myeloblastoma of the brain. Acta Neuropathol (1989) 1.16
The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat. Acta Neuropathol (1993) 1.16
The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1992) 1.14
The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol (1987) 1.14
Cerebral venous thrombosis and anticardiolipin antibodies. Stroke (1997) 1.13
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology (2006) 1.13
Temporal evolution of ischemic damage in rat brain measured by proton nuclear magnetic resonance imaging. Stroke (1991) 1.13
Cellular events during partial cerebral ischemia. I. Electron microscopy of feline cerebral cortex after middle-cerebral-artery occlusion. Virchows Arch B Cell Pathol (1977) 1.13
New ultrastructural evidence for a protein transport system in endothelial cells of gerbil brains. Acta Neuropathol (1979) 1.13
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke (2000) 1.12
DNA scission after focal brain ischemia. Temporal differences in two species. Stroke (1997) 1.11
Neuroimaging features of neurenteric cysts: analysis of nine cases and review of the literature. AJNR Am J Neuroradiol (1993) 1.10
Novel white matter tract integrity metrics sensitive to Alzheimer disease progression. AJNR Am J Neuroradiol (2013) 1.10
Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology (1999) 1.10
A quantitative comparison of motion detection algorithms in fMRI. Magn Reson Imaging (2001) 1.10
The ultrastructure of "brain death". II. Electron microscopy of feline cortex after complete ischemia. Virchows Arch B Cell Pathol (1977) 1.09
Crack-associated stroke. Neurology (1987) 1.09
Transorbital approach to the middle cerebral artery of the squirrel monkey: a technique for experimental cerebral infarction applicable to ultrastructural studies. Stroke (1972) 1.09
Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology (2006) 1.08
Pursuing the promise of an information-age health care system. Health Aff (Millwood) (1999) 1.08
Colloid cysts of the third ventricle: ultrastructural features are compatible with endodermal derivation. Acta Neuropathol (1992) 1.08
Cerebral blood flow measured by NMR indicator dilution in cats. Stroke (1989) 1.07
Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. Radiology (1992) 1.06
The effect of hypothermic circulatory arrest time on cerebral function, morphology, and biochemistry. An experimental study. J Thorac Cardiovasc Surg (1983) 1.06
The application of electron microscopy and cellular biochemistry to the autopsy. Observations on cellular changes in human shock. Hum Pathol (1975) 1.05
The metabolic effects of mild hypothermia on global cerebral ischemia and recirculation in the cat: comparison to normothermia and hyperthermia. J Cereb Blood Flow Metab (1989) 1.04
Ultrastructure of the microvasculature in experimental cerebral infarction. Acta Neuropathol (1971) 1.04
Cortical dysplasia in temporal lobe epilepsy: magnetic resonance imaging correlations. Ann Neurol (1991) 1.04
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus (2003) 1.04
Mild hypothermic intervention after graded ischemic stress in rats. Stroke (1991) 1.02
Cerebral infarction. Evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J Neuropathol Exp Neurol (1974) 1.02
High-resolution human cervical spinal cord imaging at 7 T. NMR Biomed (2011) 1.00
Analysis of temporal and spatial dichotomous PM air samples in the El Paso-Cd. Juarez air quality basin. J Air Waste Manag Assoc (2001) 1.00
The clinical significance of "adenoid" formations of neoplastic astrocytes, imitating metastatic carcinoma, in gliosarcomas. A review of five cases. Clin Neuropathol (1982) 0.99
Experimental ischemic stroke: a review. Stroke (1984) 0.98
Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology (1994) 0.98
Possible association of ischemic stroke with phentermine. Stroke (1993) 0.98
Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology (1993) 0.97
Sequential neuronal and astrocytic changes after transient middle cerebral artery occlusion in the rat. J Neurol Sci (1993) 0.97
Subacute encephalitis and hypogammaglobulinemia. Am J Dis Child (1972) 0.96
Factors associated with early presentation of acute stroke. Stroke (1993) 0.96
The effect of electrocautery, atmospheric exposure, and surgical retraction on the permeability of the blood-brain-barrier. Stroke (1972) 0.95
Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol (1990) 0.93
Evolving stroke and the ischemic penumbra. Neurology (1996) 0.93
Computed tomography in the diagnosis of Creutzfeldt-Jacob disease. J Comput Assist Tomogr (1977) 0.93
Transient focal ischemia in subhuman primates. Neuronal injury as a function of local cerebral blood flow. J Neuropathol Exp Neurol (1983) 0.93
Regional variations in the apparent diffusion coefficient and the intracellular distribution of water in rat brain during acute focal ischemia. Stroke (2001) 0.93
Masson's tumor of the kidney: a new renal lesion. J Urol (1990) 0.93